Potassium Chloride
- Product NDC
- 63323-967
- 11-digit product format
- 633230967
- Labeler code
- 63323
- Product ID
- 63323-967_a1b31b46-2bb4-457e-a30b-e7dab47a2c54
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- POTASSIUM CHLORIDE
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- ANDA088908
- Marketing category
- ANDA
- Marketing start
- 2000-09-05
- Substance
- POTASSIUM CHLORIDE
- Active strength
- 2 meq/mL
- Pharmacologic classes
- Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Potassium Chloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| POTASSIUM CHLORIDE | 2 meq/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 660YQ98I10 |
| Rxcui | 204520, 1860132, 1860136, 1860139 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63323-967-01 | Potassium Chloride | 30 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION, CONCENTRATE | 30 | | 5 |
| 63323-967-30 | Potassium Chloride | 25 in 1 TRAY | INJECTION, SOLUTION, CONCENTRATE | 25 | | 5 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| POTASSIUM CHLORIDE | ACTIVE INGREDIENT | 660YQ98I10 | POTASSIUM CHLORIDE INJECTION, SOLUTION, CONCENTRATE [APP PHARMACEUTICALS, LLC] | 1 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | POTASSIUM CHLORIDE INJECTION, SOLUTION, CONCENTRATE [APP PHARMACEUTICALS, LLC] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | POTASSIUM CHLORIDE INJECTION, SOLUTION, CONCENTRATE [APP PHARMACEUTICALS, LLC] | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | POTASSIUM CHLORIDE INJECTION, SOLUTION, CONCENTRATE [APP PHARMACEUTICALS, LLC] | 1 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | POTASSIUM CHLORIDE INJECTION, SOLUTION, CONCENTRATE [APP PHARMACEUTICALS, LLC] | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | POTASSIUM CHLORIDE INJECTION, SOLUTION, CONCENTRATE [APP PHARMACEUTICALS, LLC] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63323-967 | POTASSIUM CHLORIDE INJECTION, SOLUTION, CONCENTRATE [FRESENIUS KABI USA, LLC] | 5 | Current NDC, Legacy NDC, 2 package rows | 20230316_fcd4f458-ce27-417e-9bb6-de1cc49d44b9.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63323-967-01 | 63323096701 | 30 mL in 1 VIAL, MULTI-DOSE | 30 ml | | | | | Historical |
| 63323-967-30 | 63323096730 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-967-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-967-01) | | 2000-09-05 | 0000-00-00 | No | No | Current |